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S U M M A R Y
There are ind i rect  ind icat ions,  that  b iogenic  amines in
the bra in  are concerned wi th  patho log ica l  s ta tes such as de-
press ion (seroton in ,  5HT and noradrenal ine,  NA)  and Par-
konsonism (dopamine,  DA) .  These ind icat ions were obta ined
from measurements of amines and their metaboli tes in pe -
r ipheral f luids (such as urine and blood) and in postmortem
specimens of brain t issue of patients.
The a im of  the s tudy descr ibed in  th is  thes is  is  to  deve -
lop a  method which enables one to  measure more d i rect ly
the brain metabotr ism (and i f  possible the turnover rate) of
the amines in l iv ing individuals.
Cerebrosp ina l  f lu id  (CSF)  has d i rect  contact  w i th  bra in
t issue, and i t  was the f luj .d of choice for the investigation.
In  CSF on ly  the metabol i tes  o f  b iogenic  amines are chemi-
cal ly detectable.
Cerebra l  b iogenic  amines are loca l ized i -n  nerve ce l ls
and function probably as neurotransrnÍtters. A correlat ion
between the functional state of the aminergic neurone and the
turnover  ra te  o f  the amine ex is ts .
In animal studi.es an approximation of the ut i l izat ion of
5HT can be made bi j  inhibit ing the el imination, from the
bra in ,  o f  the main metabol i te  o f  5HT (5-hydroxy- indo iea-
cetic acid, SHIAA) by probenecid (p-(n-di-propyt sulfamoyl)
-benzoic  ac id ,  Benemid) .  From the ra te  o f  accumulat ion
of 5HIAA in the animal brain after treatment with a maxi-
mally effect ive dose of probenecid, the rate of i ts forma-
t ion can be calculated and thus the rate of sHT turnover.
Probenecid also inhibits the eff lux of a metaboli te of DA
(homovanil l ic acid, HV'A) from the brain, but not the DA
metaboli te closely related to HVA, namely dihydroxyphenyl-
acet j ,c  ac id  (DOPAC).  However  the turnover  ra te  o f  DA,
calculated from the rate of accumulation of HVA after pro-
benecid treatment, is about the half of the DA turnover rate
determined with other more rel iable methods. Probably
about  ha l f  o f  the cerebra l  DA,  in  dopaminerg ic  neurones,  is
conver tedto another  metabol i te ,  namely  3-methoxy-4-hydro-
xyphenylethanol (MOPET).
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The effects of probenecid on the brain NA metaboli tes,
3-methoxy-4-hydroxyphenylglycol (MOPEG) and the sulphate
conjugate o f  MOPEG (MOPEG -su lphate)  has not  yet  been des-
c r i bed .
This  thes is  cons is ts  o f  two major  par ts :
I  Development of reLiable methods for the determination
of amime metaboli tes and probenecid in small  samples of
human lumbar CSF.
II  The effect of probenecid ( intravenously and oral ly ad-
ministered) on the amine metaboli tes in CSF of. human beings.
The main resu l ts  'were:
I ANALYTICAL METHODS.
Inl i terature only f luorometric methods for 5HIAA, DOPAC
and HVA for  CSF measurements  are descr ibed.  For  re l iab le
detection of al l  compounds (thus including SHIAA, HVA,
MOPEG, MOPEG-sulphate and probenec id)  too large amounts
of the f luid are needed. Many improvements of the methods
descr ibed in  the l i te ra ture \ ryere in t roduced.
The amine metaboli tes are f irst quanti tat ively separated on
Sephadex G 10 (a  commerc ia l  dext ran) ,  and then detected
f luorometrical ly.
The f luorometr ic  methods were par t ly  der ived f rom l i te-
rature (DOPAC and HVA), part ly developed by ourselves
(MOPEG and MOPEG -su lphate)  or  improved (5HIAA) .
Probenecid was quanti tat ively isolated from plasma and
CSF by  means  o f  Sephadex  G10  and  de tec ted  by  U .V .  ab -
sorpt ion.
Mean levels of metaboli tes found in human lumbar CSF
( in  ng/ml) ,  w i thout  probenec id  pret reatment  are:  SHIAA:  40;
HVA:  40 ;  MOPEG:  29 ;  MOPEG -su lpha te :  14  and  DOPAC:  (  10 .
These values correspond rather well  with those found by
others .
II PROBENECID TEST.
1.  Probenec id  induces an increase of  the leve ls  o f  SHIAA
and HVA in the lumbar CSF, as v/as confirmed also
bv analys is  o f  f luorescence spect ra .
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2. After treatrnent with probenecid (1 g intravenously
administered within 20 min) HVA and 5HIAA in the
Iumbar CSF did not accumulate within about 4 hours.
The lag phase of about 4 hours represents probably
the t ime of dif fusion of the accumulated acids from
the bra in  to  the lumbar  space.  E ight  hours  a f ter  the
the start of the probenecid test the accumulation was
maximal.
3 .  Treatment  o f  pat ients  wi th  ra ther  h igh doses of  pro-
benecid (1 g intravenously plus 2 - 4 g oral1y) did
not induce measurable accurnulat ion of DOPAC, MO -
PEG and MOPEC-sulphate.
4 .  A s i -gn i f icant  cor re la t ion between the leve ls  o f  pro-
benecid and the increase of the concentrat ion of HVA
and SHIAA in lumbar CSF was found after loading of
pat ients  wi th  3-4 g  o f  probenec id .
Wi th  the probenec id  tes t  descr ibed in  th is  thes is ,  i t  seems
to be possible to study SHT and DA metabolism in the hu-
man brain. No information can be obtained concerning the
cent ra l  NA metabol ism wi th  the methods descr ibed.
The re levance of  the resu l ts  obta ined by the probenec id
test  were d iscussed,  and some uncer ta in t ies  were ind icated.
Some resu l ts  o f  c l in ica l  s tud ies (Park insonism and depres -
s ion)  are ment ioned.
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